购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-36 (compound 116), 作为hydroxysteroid 17?-dehydrogenase 13 (HSD17B13) 的有效抑制剂,在雌二醇作为底物时,其IC50? 小于 0.1 μM。该化合物在非酒精性脂肪性肝炎(NASH)等非酒精性脂肪肝疾病 (NAFLD) 的研究中具有关键作用。
HSD17B13-IN-36 (compound 116), 作为hydroxysteroid 17?-dehydrogenase 13 (HSD17B13) 的有效抑制剂,在雌二醇作为底物时,其IC50? 小于 0.1 μM。该化合物在非酒精性脂肪性肝炎(NASH)等非酒精性脂肪肝疾病 (NAFLD) 的研究中具有关键作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-36 (compound 116) serves as a potent inhibitor of hydroxysteroid 17?-dehydrogenase 13 (HSD17B13), exhibiting an IC50 of <0.1 μM with estradiol as substrates. This compound is significant in the management of nonalcoholic fatty liver diseases (NAFLDs), including NASH (nonalcoholic steatohepatitis) [1]. |
分子量 | 433.43 |
分子式 | C20H17F2N3O4S |
CAS No. | 2730027-86-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容